Cell-Based Therapy for Osteoarthritis

Osteoarthritis is the most common chronic condition of the joints. The symptoms of osteoarthritis include pain, swelling, and stiffness around the joints, which are caused by the degeneration of the articular cartilage. Traditionally, treatments focus on pain management and symptom alleviation instead of reversing the damages. Some conventional therapies have side effects on the digestive system, kidneys, and heart. Some of the adverse effects are even life-threatening. On the other hand, traditional surgery is invasive and has limited efficacy in treating osteoarthritis.

With the newest research and advancements in the medical field, cell-based therapy has shown promising results in treating osteoarthritis. At BrioMD, we offer groundbreaking new technology with high efficacy and adhere to the strictest safety standards set forth by the FDA, so that osteoarthritis patients may have a second chance at a better daily living experience.

What is cell-based therapy?

In cell-based therapy, stem cells or other cellular products are used for tissue regeneration purposes. It involves the transplantation of human cells to replace or repair damaged tissue and cells. Cell-based therapy can be applied in regenerative medicine, immunotherapy, and cancer treatment. In the case of osteoarthritis, these cells can turn into cartilage and potentially reverse the damage to the joints. They release not only growth factors but also anti-inflammatory factors, so that the damaged joints may heal faster.

What are the new treatment options for osteoarthritis?

• Platelet-rich plasma
• Regenokine
• Stem cells
• Exosome

Among the cellular options, mesenchymal stem cells (MSCs) have been studied heavily in recent years and showed positive clinical results for their regenerative properties. MSCs are found primarily in bone marrow and fat. They have been used in cell-based therapy for decades. Clinical trials have shown positive outcomes with minimal side effects.

Exosomes are derived from cells, contain cell-specific receptors, and are important in cell-to-cell communication. MSC-derived exosomes were shown to be able to repair cartilage and delay osteoarthritis progression.

How about treatment safety?

The BrioMD cell-based therapy is minimally invasive and essentially pain-free. Cell-based therapy is under the FDA’s regulation of human cells, tissues, and cellular and tissue-based products. BrioMD and its partner lab adhere to the strictest safety standards set forth by the FDA. Our unique process yields the highest number of cells without using any enzymes or other additives. The cells harvested from your body are not altered in any way or manipulated by drugs, enzymes, or growth factors. With our patented technology, BrioMD proudly offers highly effective and safe cell-based therapy.

What is the treatment process?

The BrioMD treatment process is described in detail on our website. For you, as a patient, the cell harvesting process takes about 60 minutes. The therapy takes two to three hours per session, and the number of sessions is precisely calculated by our team based on your conditions and may range from one to ten sessions.

Contact us today

BrioMD uses the safest and most advanced treatments in the world to help patients in need. If you are among the 350 million people worldwide suffering from arthritis and are looking for better treatment options, we are here to help. Fill out the form below to contact our team and learn more about cell-based therapy for osteoarthritis.